Analyst consensus rating
Cyclerion Therapeutics Analyst Rating: none
Direct answer
Cyclerion Therapeutics's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.00.
Forecast evidence checked September 6, 2026.
Get free Cyclerion Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.25
- Average price target
- $8.00
- High price target
- $8.00
- Low price target
- $8.00
- Low target gap
- +88.2%
- Target upside
- +88.2%
- High target gap
- +88.2%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- September 6, 2026
- Valid through
- September 13, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Cyclerion Therapeutics?
Cyclerion Therapeutics has a verified none consensus. The same dataset has an average price target of $8.00.
How far are Cyclerion Therapeutics's low and high targets from the recorded price?
The low target implies +88.2%, while the high target implies +88.2%.
How many analysts are included in Cyclerion Therapeutics's consensus?
The verified consensus includes 1 analysts.
How is Cyclerion Therapeutics's target upside or downside calculated?
The average target of $8.00 is divided by the recorded price of $4.25, then one is subtracted to produce +88.2%. This does not guarantee a future return.
When was Cyclerion Therapeutics's analyst forecast verified?
The data was verified on 2026-09-06. The dataset is valid through 2026-09-13.